Hospitalization for variceal hemorrhage in an era with more prevalent cirrhosis

Figure 1 Mean model of end stage liver disease scores for study population per year. P value = 0.20 reflects trend for MELD scores for cirrhosis of all causes. P value = 0.27 reflects comparison of ALC and NALC groups. MELD: Model for end-stage liver disease; All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.

Figure 2 Admissions with cirrhosis per 100000 IP visits based on etiology of cirrhosis. P values are for trend. All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.

Figure 3 Trends in admissions for variceal bleeding per 100000 inpatient visits based on etiology of cirrhosis. A: Total variceal bleeds; B: Index variceal bleeds; C: Variceal rebleeding. P values are for trend during study period. All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.

Figure 4 Transjugular intrahepatic portosystemic shunt placement 1998-2009. P values are for trend. TIPS: Transjugular intrahepatic portosystemic shunt; GI: Gastrointestinal.

Figure 5 Hospital deaths per 100000 admissions based on etiology of cirrhosis. P value is for trend. All: Cirrhosis all causes; ALC: Alcoholic cirrhosis; NALC: Non-alcoholic cirrhosis.

Figure 6 Non-selective beta-blocker usage amongst patients with variceal index bleeding and recurrent variceal bleeding. NSBB: Nonselective beta-blocker. P values are for trend.